ARTICLE | Company News
Cellectis, Zentaris cancer deal
August 30, 2001 7:00 AM UTC
Cellectis (Paris, France) granted Zentaris (Frankfurt, Germany) access to its single long terminal repeats (sLTR) technology for cancer gene therapy. Zentaris' MainGen Biotechnology subsidiary will us...